Chai Discovery is a startup based in the United States, most recent round Series A, 3 tracked investors.
Based in the United States, Chai Discovery is a startup founded in 2025. Its most recent tracked round is Series A. Brouky records 3 investors associated with the company.
Chai Discovery develops generative AI platforms that design antibodies and other biologic molecules at the atomic level to accelerate drug discovery and improve binding prediction without extensive experimental screening.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.